foxo4 dri peptide senolytic mouse study 2023

foxo4 dri peptide senolytic mouse study 2023 Frontiers FOXO4-DRI part 1 #peptide #molecule

Name: foxo4 dri peptide senolytic mouse study 2023 Frontiers FOXO4-DRI part 1 #peptide #molecule
Brand: metron-ms.com
SKU: 17639734313
Price: 25.18 USD
Availability: InStock
Rating: 4.729 (12 reviews)

FOXO4 DRI part 1 #peptide #molecule #research #health #information FOXO4 peptide targets myofibroblast ameliorates bleomycininduced pulmonary fibrosis in mice through ECMreceptor interaction pathway Han 2022 Journal of Cellular and Molecular Medicine Wiley Online Library Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PMC The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

SKU: 17639734313 · From metron-ms.com

4.7

USD25.18 USD57.18

Pay in 4 interest-free payments of $6.29 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Who Should Consider Rapid Release

and responsibilities of each of the stakeholders, as well as any required Phase III assistance (including funding)

& Bello-Lpez, M

NUPR1 is emerging as a potential target in oncology, including for lung cancer 66,77,78 , because NUPR1 supports survival, therapy resistance, and stress adaptation of tumor cells 64,79,80